- Home
- GH vs INSP Comparison
GH vs INSP Comparison
Compare GH & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- INSP
- Stock Information
- Founded
- GH 2011
- INSP 2007
- Country
- GH United States
- INSP United States
- Employees
- GH N/A
- INSP N/A
- Industry
- GH Medical Specialities
- INSP Medical/Dental Instruments
- Sector
- GH Health Care
- INSP Health Care
- Exchange
- GH Nasdaq
- INSP Nasdaq
- Market Cap
- GH 4.7B
- INSP 5.3B
- IPO Year
- GH 2018
- INSP 2018
- Fundamental
- Price
- GH $45.13
- INSP $185.09
- Analyst Decision
- GH Strong Buy
- INSP Buy
- Analyst Count
- GH 14
- INSP 11
- Target Price
- GH $39.93
- INSP $231.64
- AVG Volume (30 Days)
- GH 1.9M
- INSP 614.6K
- Earning Date
- GH 02-20-2025
- INSP 02-10-2025
- Dividend Yield
- GH N/A
- INSP N/A
- EPS Growth
- GH N/A
- INSP N/A
- EPS
- GH N/A
- INSP 1.09
- Revenue
- GH $692,256,000.00
- INSP $755,594,000.00
- Revenue This Year
- GH $32.21
- INSP $29.96
- Revenue Next Year
- GH $16.90
- INSP $19.49
- P/E Ratio
- GH N/A
- INSP $169.16
- Revenue Growth
- GH 29.20
- INSP 32.52
- 52 Week Low
- GH $15.81
- INSP $123.00
- 52 Week High
- GH $45.66
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- GH 79.68
- INSP 47.88
- Support Level
- GH $36.45
- INSP $170.75
- Resistance Level
- GH $39.29
- INSP $216.01
- Average True Range (ATR)
- GH 2.35
- INSP 8.56
- MACD
- GH 0.75
- INSP -1.84
- Stochastic Oscillator
- GH 96.63
- INSP 34.60
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.